For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Learning from the COVID-19 response to avoid history repeating
Learning from the COVID-19 response to avoid history repeating

Occupational health expert David McBride reviews New Zealand’s COVID-19 response, including the lessons learnt and how we can be better prepared in future
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Ministry of Health. Aotearoa New Zealand Strategic Framework for Managing COVID-19. Wellington, NZ: Ministry of Health; 2023.
2. Walls C, Emrys G, Gavaghan S, et al. A model respiratory personal protective programme for the New Zealand healthcare industry. N Z Med J 2020;133(1522):161–66.
3. Boyle AB, Shay D, Martyn T, et al. Burnout in New Zealand resident doctors: a cross-sectional study of prevalence and risk factors. BMJ Open 2025;15(1):e089034.
4. Gorman D, Horn M. Time for a sea change in our COVID-19 management. N Z Med J 2020;133(1520):12–14. Published 2020 Aug 21.
5. Betty B, Scott-Jones J, Toop L. State of general practice in New Zealand. N Z Med J 2023;136(1582):8–10.
6. Te Whatu Ora. Health workforce plan 2023/24. Wellington, NZ: Te Whatu Ora and Te Aka Whai Ora; July 2023.
7. Te Whatu Ora. New Zealand Health Workforce Plan. Wellington, NZ: Te Whatu Ora; December 2024.